Strategic Vaccines LLC
An Alliance to Save Lives
Strategic Vaccines will be domiciled within the Texas A&M Center for Innovation in Advanced Development and Manufacturing (CIADM) to develop the vaccine/therapeutic.
Read More Here
In order to support America's response to the COVID Pandemic, M7TecGroup teamed up with Flow Pharma and Texas A&M University System to develop and produce, in volume, a T-Cell Synthetic Vaccine and Therapeutic to combat SARS-CoV2 in 2020.
We are Different
Our Vaccine and Therapeutic system is synthetic and uses peptide platform technology to build immunity or directly attack the Virus's RNA.
We are Safer
T-Cell Vaccines do not contain a live virus;
FDA primate trials are 100% successful.
Our vaccine is inhaler/injection available.